case rePort
A 32-year-old Saudi male with no comorbidities and independent in his activities of daily living presented with a history of breathlessness on and off for the past 3 months. It worsened with travel to 2200-m high altitude. In the emergency room, the patient was drowsy with the chief complaints of severe dyspnea, headache, myalgia, and swelling and pain in the lower limb. There was no history of any chronic respiratory diseases. He was afebrile. His heart rate was 115-120 beats/min and regular, respiratory rate was 35-40 breaths/min, blood pressure was 150/90 mmHg, and oxygen saturation was 74% on room air. Physical examination revealed a weight of 283 kg, BMI >92 m 2 , height of 175 cm with a neck circumference of 55 cm, cyanotic nail beds, mild jugular distension, and higher central fat distribution. He was drowsy but easily arousable. Glasgow Coma Scale (GCS) score was 11. In the emergency room, he was treated with O 2 15 L/min, and the oxygen saturation rose to 90%-91%. His blood biochemistry was within normal limits. His treatment included intravenous fluids (5% dextrose normal saline with 20 mEq potassium chloride added, hydrocortisone 100 mg TID, amoxicillin 1 g TID, inhaled ipratropium bromide 6 th hourly, inhaled salbutamol 6 th hourly, furosemide 20 mg BID, and unfractionated heparin 7500 SC TID). Arterial blood gas analysis (ABG) was obtained, and sputum for cultures was collected. Anteroposterior chest X-ray revealed bilateral increased bronchovascular markings and cardiomegaly [ Figure 1 ]. Electrocardiogram showed sinus tachycardia. Echocardiography showed dilated right ventricle and mild tricuspid regurgitation. A computed tomography (CT) scan could not be performed to detect pulmonary embolism because the CT table could not accommodate his weight. His initial ABG in the emergency room showed hypoxia and respiratory acidosis (pH 7.26, PCO 2 86 mmHg, PO 2 27.9 mmHg, and HCO 3 29.6 mmol/L).
The diagnosis at admission was OHS with OSA, cor pulmonale, and cellulitis. His condition deteriorated subsequently with desaturation to 76% even with 15 L/min of oxygen. Therefore, the patient was transferred to the ICU for further management. A trial of NIV was given along with other conventional treatment. ABG repeated before NIV showed severe respiratory acidosis (pH 7.15, PO 2 65 mmHg, PCO 2 113 mmHg, and HCO 3 27.6 mmol/L) [ Table 2 ]. Intubation and invasive ventilation was planned if the respiratory rate increased to >40 breaths/min or if there was any drop in GCS level. To avoid aspiration and to deliver adequate ventilation, high Fowler's position was adopted. The NIV-Bi-level ST Philips Respironics V 60, California, USA) is a single-circuit, pressure-targeted, nonvent mask provided with a calibrated leak. The following settings were used: respiratory rate was set at 25 b/min as backup, inspiratory positive airway pressure (IPAP) of 10 cmH 2 O was initiated to overcome upper airway resistance and to reduce the work of breathing (WOB), and expiratory positive airway pressure (EPAP) of 5 cmH 2 O was initiated to prevent alveoli collapse at the end of each respiratory cycle. To provide more time for expiration and to reduce WOB, an inspiration and expiration time ratio was set at 1:4. After 2 h of NIV, ABG showed pH 7.12, PCO 2 136 mmHg, and PO 2 77.3 mmHg. IPAP was increased in steps of 3 cmH 2 O and EPAP in steps of 1 cmH 2 O, every 15 min based on the WOB, minute ventilation, respiratory rate, and ABG results. Adequate tidal volume was reached with IPAP 22 cmH 2 O and EPAP 10 cmH 2 O (as tolerated by the patient). Subsequently, as the patient improved, NIV could be gradually reduced to IPAP of 12 cmH 2 O and EPAP of 5 cmH 2 O based on ABG and respiratory mechanics. FiO 2 was adjusted between 45% and 80% to keep the SpO 2 92%. NIV was disconnected only during feeding. Weight reduction also being a potential therapy to improve patients' long-term medical condition, injection liraglutide 3 mg subcutaneous once daily with a plan to escalate dose from 0.6 mg to 3 mg each week from day 2 was considered.
The patient was monitored closely with hourly recording of all vitals; ABG was repeated at 2 h, 4 h, and every 6 h [ Table 2 ]. After 70 h of continuous NIV, the patient's clinical condition improved significantly, along with a reduction in PCO 2 to 42.8 mmHg. The reduction in PCO 2 over 70 h of NIV is shown in Figure 2 . The post-NIV ABG result at the 6 th h was within normal range. The patient was discharged to the ward on day 8 as shown in Figure 3 . Normal weight 25.0-26. 9 Overweight 27.0-34. 9 Class I obese 35.0-39. 9 Class II obese 40.0-49. 9 Class III obese 50-59. 9 Class IV super obese >60
Class V extreme super-super obese BMI: Body mass index In addition to conventional treatment, NIV was the dominant part of the successful management of this patient. Some obese patients with respiratory etiology are misdiagnosed with chronic obstructive pulmonary disease (COPD) and asthma. [5] Similarly, this patient was initially diagnosed and treated as exacerbation of COPD although the clinical diagnosis supported OHS. Physicians should be more cautious about the diagnosis of OHS in this background. In comparison with OSA or eucapneic obese patients, the central fat distribution is found to be higher in OHS, and their respiratory muscles are primarily affected by hypoventilation, larger neck circumference, and high waist: hip ratios. [8] Notably, in this case, the higher central fat distribution reduced the respiratory muscle efficiency, resulting in more significant reduction in lung volume and increased WOB. These features worsened in lying and supine positions due to the cephalic displacement of the diaphragm. Hence, high Fowler's position was adopted for 70 h of NIV (Bi-level ST). PCO 2 reduction was significant as shown in similar studies demonstrating consistent improvement in awake blood gases and daytime sleepiness with NIV as compared to continuous positive airway pressure (CPAP). [8, 9] This patient required higher positive end-expiratory pressure of 10 cmH 2 O and a higher IPAP of 22 cmH 2 O for longer duration before reduction of PCO 2 to below 50 mmHg could be achieved. Many comprehensive studies conclude the same result that the NIV is beneficial; it can prevent intubation and associated complications in selected patients. NIV not only enhanced the pulmonary gas exchange but also reduced a load on inspiratory muscles and improved the respiratory mechanics of our patient. In the long term, weight reduction is helpful. [10, 11] conclusIon The NIV was beneficial in this extreme super-super obese patient with BMI >92 kg/m 2 with OHA who presented with Type II respiratory failure. NIV prevented intubation and mechanical ventilation complications. Physicians should be aware that each obese patient may not be a candidate for NIV. Awake hypercapnia and hypoxia may persist despite the effective use of NIV. A randomized controlled trial on the use of NIV is recommended in this group of patients.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient has given his consent for his images and other clinical information to be reported in the journal. The patient understands that his names and initials will not be published and due efforts will be made to conceal his identity, but anonymity cannot be guaranteed.
